Geovax Labs Stock Performance
GOVX Stock | USD 1.85 0.01 0.54% |
The company retains a Market Volatility (i.e., Beta) of 2.12, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GeoVax Labs will likely underperform. GeoVax Labs has an expected return of -1.62%. Please make sure to check out GeoVax Labs total risk alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if GeoVax Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:15 | Dividend Date 2020-09-25 | Last Split Date 2024-01-31 |
1 | GeoVax Announces Gedeptin Patient Enrollment Closure for Phase 12 Clinical Trial Among Advanced Head and Neck Cancer Patients | 01/04/2024 |
2 | GeoVax Labs Trading Down 13.1 percent - MarketBeat | 01/31/2024 |
3 | Purchase by Mark Reynolds of 2000 shares of GeoVax Labs | 02/07/2024 |
4 | GeoVax strengthens intellectual property on vaccines | 02/13/2024 |
5 | POP ON VENEERS PARTNERS WITH GOVX, BRINGING SMILES TO MEMBERS ACROSS THE U.S. AT A DISCOUNTED COST | 02/21/2024 |
6 | Acquisition by David Dodd of 8209 shares of GeoVax Labs at 2.2735 subject to Rule 16b-3 | 02/22/2024 |
7 | GeoVax Reports 2023 Year-End Financial Results and Provides Business Update | 02/29/2024 |
8 | GeoVax Labs Shares Down 3.6 percent - Defense World | 03/26/2024 |
Begin Period Cash Flow | 27.6 M |
GeoVax |
GeoVax Labs Relative Risk vs. Return Landscape
If you would invest 542.00 in GeoVax Labs on December 29, 2023 and sell it today you would lose (357.00) from holding GeoVax Labs or give up 65.87% of portfolio value over 90 days. GeoVax Labs is currently does not generate positive expected returns and assumes 4.9399% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than GeoVax, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
GeoVax Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeoVax Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GeoVax Labs, and traders can use it to determine the average amount a GeoVax Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3288
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | GOVX |
Estimated Market Risk
4.94 actual daily | 43 57% of assets are more volatile |
Expected Return
-1.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.33 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GeoVax Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeoVax Labs by adding GeoVax Labs to a well-diversified portfolio.
GeoVax Labs Fundamentals Growth
GeoVax Stock prices reflect investors' perceptions of the future prospects and financial health of GeoVax Labs, and GeoVax Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GeoVax Stock performance.
Return On Equity | -1.6 | ||||
Return On Asset | -0.82 | ||||
Current Valuation | (2.46 M) | ||||
Shares Outstanding | 2.17 M | ||||
Price To Earning | (1.25) X | ||||
Price To Book | 0.69 X | ||||
Price To Sales | 59.01 X | ||||
Gross Profit | 81.53 K | ||||
EBITDA | (26.67 M) | ||||
Net Income | (25.97 M) | ||||
Cash Per Share | 1.25 X | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 9.51 X | ||||
Cash Flow From Operations | (25.17 M) | ||||
Earnings Per Share | (14.29) X | ||||
Total Asset | 9.28 M | ||||
Retained Earnings | (104.36 M) | ||||
Current Asset | 1.24 M | ||||
About GeoVax Labs Performance
To evaluate GeoVax Labs Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when GeoVax Labs generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare GeoVax Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand GeoVax Labs market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents GeoVax's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | (4.64) | (4.41) | |
Return On Assets | (2.80) | (2.94) | |
Return On Equity | (4.51) | (4.28) |
Things to note about GeoVax Labs performance evaluation
Checking the ongoing alerts about GeoVax Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GeoVax Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.GeoVax Labs generated a negative expected return over the last 90 days | |
GeoVax Labs may become a speculative penny stock | |
GeoVax Labs has high historical volatility and very poor performance | |
GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 81.53 K. | |
GeoVax Labs currently holds about 30.9 M in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
GeoVax Labs has a poor financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: GeoVax Labs Shares Down 3.6 percent - Defense World |
- Analyzing GeoVax Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GeoVax Labs' stock is overvalued or undervalued compared to its peers.
- Examining GeoVax Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GeoVax Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GeoVax Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GeoVax Labs' stock. These opinions can provide insight into GeoVax Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for GeoVax Stock analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is GeoVax Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GeoVax Labs. If investors know GeoVax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GeoVax Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.29) | Quarterly Revenue Growth (1.00) | Return On Assets (0.82) | Return On Equity (1.60) |
The market value of GeoVax Labs is measured differently than its book value, which is the value of GeoVax that is recorded on the company's balance sheet. Investors also form their own opinion of GeoVax Labs' value that differs from its market value or its book value, called intrinsic value, which is GeoVax Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GeoVax Labs' market value can be influenced by many factors that don't directly affect GeoVax Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GeoVax Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeoVax Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeoVax Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.